Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPermnt Tsb 30 Regulatory News (73HR)

Share Price Information for Permnt Tsb 30 (73HR)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
73HR Live PriceLast checked at - London Stock Exchange

Intraday Permnt Tsb 30 Share Chart

Repurchase Contingent Convertible Notes

23 Apr 2015 07:00

RNS Number : 0593L
Permanent TSB Group Holdings PLC
23 April 2015
 



headline: permanent tsb Group Holdings PLC announces the repurchase of €400m 10% contingent Convertible notes from the irish state

Update

Pursuant to the recent announcements in respect of its capital plans, permanent tsb Group Holdings plc (the "Group") today announces that it has agreed terms for the repurchase of the €400m 10% Contingent Convertible Notes from the Irish State at a premium of €10.544m.

Transaction details

The repurchase will be contingent upon the successful execution of the previously announced forthcoming capital raise of €525m, consisting of €400m of new equity and €125m of an Additional Tier 1 instrument, to be raised from private investors. This, together with other capital measures will satisfy the capital shortfall identified in the adverse scenario of the 2014 Single Supervisory Mechanism Comprehensive Assessment (SSM CA).

The Group has agreed a clean price for the repurchase of 102.636, representing a premium payable of €10.544m in addition to the €400m principal and accrued interest.

The Directors consider, having consulted with the Group's ESM advisor Davy, that the terms of the transaction are fair and reasonable insofar as the shareholders are concerned.

Financial Effect

The net benefit to the Group is the saving of future interest payments of c.€49m offset by the premium of €10.544m.

In the Income Statement of the Group, as measured on an Effective Interest Rate basis under IFRS, this will be presented as an aggregate loss on repurchase of c.€52m in H1 2015, which is offset by future interest expense savings of c.€90m.

Background

The €400m 10% Contingent Convertible Notes were issued by the Group's subsidiary permanent tsb plc (ptsb) on 27 July 2011 following the conclusion of the Prudential Capital Assessment Review. The notes had an original term of 5 years and were due to mature on 28 July 2016.

The key terms and conditions of the Contingent Convertible Notes are detailed as follows:

· The coupon interest rate is fixed at 10% payable annually in arrears which can be increased to 18% if the Minister for Finance wishes to re market the notes;

· The notes are convertible into the ordinary shares of permanent tsb Group Holdings plc, the parent of ptsb, in the occurrence of a Conversion Event;

· Conversion Event is defined as the occurrence of 1) a Capital Deficiency Event where ptsb's core Tier 1 capital falls below 8.25% or the Central Bank of Ireland notifies ptsb, that it has determined that its financial and solvency condition is deteriorating in such a way that a Capital Deficiency Event is likely to occur in the short term and/or 2) a Non-Viability Event where the ECB determines that ptsb may become insolvent or unable to pay its debts as they fall due, as defined in the related Agency Deed.

 Rationale for repurchasing

The Contingent Convertible Notes do not count as qualifying capital for the purposes of the SSM CA unless they are converted to equity. Thus, the only circumstances in which the Contingent Convertible Notes could be utilised to address the capital shortfall would be by way of their conversion into Ordinary Shares (which could only occur in circumstances where a conversion event of such Contingent Convertible Notes had occurred and no such conversion event has occurred).

Any conversion of the Contingent Convertible Notes in those circumstances would also further increase the equity holding of the Irish State in the Group and could amount to a new injection of State aid.

In addition, repurchasing the Contingent Convertible Notes will significantly reduce the associated interest costs of the Group in 2015 and 2016 in respect of such Contingent Convertible Notes.

It is expected that the repurchase will be completed on the agreed terms without delay following the completion of the capital raise.

 

Ciarán Long

Group Secretary

 

 

Contact Details

Glen Lucken,

Group Chief Financial Officer

Tel: +353 1 669 5145

 

Media:

Ray Gordon

Gordon MRM

ptsb@gordonmrm.ie

Mobile +353 87 241737

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREAELAADPSEAF
Date   Source Headline
29th Aug 20187:00 amRNS2018 Half-Year Results Commentary
31st Jul 20182:15 pmRNSSale of Non Performing Loan Portfolio
27th Jul 20187:00 amRNSDirectorate Change
24th Jul 201811:00 amRNSDirectorate Change
16th May 20187:00 amRNSTrading Statement
4th May 20184:29 pmRNS?5,000,000,000 Euro Note Programme
6th Apr 20183:00 pmRNSCourt approval for cancellation of deferred shares
29th Mar 201811:34 amRNSAnnual Financial Report
14th Mar 20187:00 amRNS2017 Annual Results Commentary
14th Mar 20187:00 amRNSAnnual Financial Report
21st Dec 20177:00 amRNS2017 Supervisory Review and Evaluation Process
8th Nov 20177:00 amRNSTrading Statement
27th Jul 201710:00 amRNSHalf-year Report
26th Jul 20177:00 amRNS2017 Half-Year Results Commentary
26th Jul 20177:00 amRNSHalf-year Report
10th May 20174:45 pmRNSConfirmation of Director Appointment
10th May 20177:00 amRNSTrading Update
12th Apr 20173:29 pmRNSRemoval of Notes - ISIN XS0214072752
3rd Apr 201710:00 amRNSAnnual Financial Report
31st Mar 201711:00 amRNSChairman Appointment Update/New Company Secretary
8th Mar 20177:00 amRNSAnnual Financial Report Commentary
7th Mar 20172:00 pmRNSAppointment of Chairman
21st Dec 20163:00 pmRNSSupervisory Review & Evaluation Process Update
13th Dec 20162:30 pmRNS2016 Supervisory Review and Evaluation Process
10th Nov 20167:00 amRNSTrading Statement
27th Oct 20167:00 amRNSSale Agreed for Non-Core UK Assets
26th Oct 20163:00 pmRNSDirectorate Change (Chairman)
27th Sep 201610:00 amRNSDirectorate Change
29th Jul 20164:00 pmRNSTypographical Error in Half Year Report
27th Jul 20163:00 pmRNSHalf-year Report
27th Jul 20167:00 amRNSHalf-Year Results Commentary
11th May 20167:00 amRNSTrading Statement
19th Apr 201611:15 amRNSAppointment of Chief Risk Officer
16th Mar 20164:30 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSAnnual Financial Report
9th Mar 20167:00 amRNSAnnual Results Commentary
10th Nov 20157:00 amRNSTrading Statement
18th Aug 20153:00 pmRNSSenior Management Changes
29th Jul 20153:00 pmRNSHalf Yearly Report
28th Jul 20158:30 amRNSPreliminary 2015 Half Year Results
17th Jul 20153:00 pmRNSSenior Management Change
1st Jul 20157:00 amRNSStandard Variable Rate Mortgage Pricing Update
7th May 201510:11 amRNSCancellation of Notes
27th Apr 20155:51 pmRNSAnnouncement of Open Offer Terms and Timetable
27th Apr 20155:49 pmRNSPlacing of Shares - Announcement of Offer Price
27th Apr 201511:31 amRNSPre-Stabilisation Notice - Perm TSB Perpetual
23rd Apr 20157:00 amRNSRepurchase Contingent Convertible Notes
14th Apr 20157:00 amRNSTrading Statement
14th Apr 20157:00 amRNSCapital Raising Update
9th Apr 20153:04 pmRNSApproval of pemanent tsb Restucturing Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.